Overcoming Obesity: Insights from the SURMOUNT-4 Trial

Host: John Buse, MD, PhD Guest: Louis J. Aronne, MD, FTOS In the SURMOUNT-4 trial, 100 patients with obesity were on tirezpatide for 9 months, and the average weight loss was 20.9 percent. The patients were then randomized to receive either placebo with behavioral intervention or tirzepatide for another year, and the patients in the former group regained a significant amount of weight. Dive further into the study’s findings and implications with Dr. John Buse and Dr. Louis Aronne, the Sanford I. Weill Professor of Metabolic Research at Weill Cornell Medical College in New York.

You can listen to Overcoming Obesity: Insights from the SURMOUNT-4 Trial online on Radio and Podcast. Open the player on this page to stream the available audio.

Overcoming Obesity: Insights from the SURMOUNT-4 Trial is an episode from Diabetes Discourse by ReachMD.

This episode is 00:12:30 long.

This episode was published on Mar 27, 2024.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Diabetes Discourse when more episodes are available from the podcast feed.